Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the σ1 chaperone protein

Autor: García-Pupo, Laura, Crouzier, Lucie, Bencomo-Martínez, Alberto, Meunier, Johann, Morilleau, Axelle, Delprat, Benjamin, Carrazana, Marquiza Sablón, Menéndez Soto del Valle, Roberto, Maurice, Tangui, Rodríguez-Tanty, Chryslaine
Zdroj: In Acta Pharmaceutica Sinica B October 2024 14(10):4345-4359
Databáze: ScienceDirect